Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CINEWORLD GROUP PLC Remuneration Information 2019

Nov 11, 2019

5311_rns_2019-11-11_20124389-e197-4c1c-bc5a-9da384a82661.html

Remuneration Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9579S

Cineworld Group plc

11 November 2019

BLOCK LISTING SIX MONTHLY RETURN

Date: 11 November 2019

Name of applicant:

CINEWORLD GROUP PLC

Name of schemes:

Cineworld Group 2007 Sharesave Scheme

Cineworld Group 2007 Performance Share Plan

Cineworld Group plc Company Share Option Plan

Period of return:

From:

09/05/2019

To:

08/11/2019

Balance of unallotted securities under scheme(s) from previous return:

Sharesave Scheme 39,104
Performance Share Plan 181,542
Company Share Option Plan 70,396
Total: 291,042

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Sharesave Scheme 0
Performance Share Plan 650,000
Company Share Option Plan 0
Total: 650,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Sharesave Scheme 1,106
Performance Share Plan 785,724
Company Share Option Plan 0
Total: 786,830

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

Sharesave Scheme 37,998
Performance Share Plan 45,818
Company Share Option Plan 70,396
Total: 154,212

All figures refer to ordinary shares of 1p each

Name of contact: Fiona Smith
Telephone number of contact: 0208 987 5000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BLRCKDDQCBDKADD